Accueil   Diary - News   All news Adocia Files Patent

Adocia Files Patent



Adocia Files Patent for Technology to Enable Oral Drug Delivery of Peptides



• Adocia's technology has shown promising in vivo results with the oral administration of a GLP-1 receptor agonist for the treatment of diabetes

• First-in-Human clinical study planned for 2022 to establish proof of concept

• The potential of this technology is being assessed across different therapeutic peptides and proteins



Read the press release